Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine

BACKGROUND: Upper gastrointestinal (GI) symptoms such as nausea and vomiting are common adverse events associated with selective serotonin reuptake inhibitors (SSRIs), and may result in discontinuation of drug therapy in patients with depressive disorder. Rikkunshi-to (formulation TJ-43), a traditio...

Descripción completa

Detalles Bibliográficos
Autores principales: Oka, Takakazu, Tamagawa, Yoko, Hayashida, Sota, Kaneda, Yuko, Kodama, Naoki, Tsuji, Sadatoshi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2204024/
https://www.ncbi.nlm.nih.gov/pubmed/18001480
http://dx.doi.org/10.1186/1751-0759-1-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2204024/
https://www.ncbi.nlm.nih.gov/pubmed/18001480
http://dx.doi.org/10.1186/1751-0759-1-21

Ejemplares similares